Oric Pharmaceuticals Stock Investor Sentiment
| ORIC Stock | USD 9.80 0.07 0.71% |
About 67% of Oric Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Oric Pharmaceuticals suggests that many traders are alarmed. The current market sentiment, together with Oric Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Oric Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Oric |
Oric Pharmaceuticals Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Oric Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Oric Pharmaceuticals that are available to investors today. That information is available publicly through Oric media outlets and privately through word of mouth or via Oric internal channels. However, regardless of the origin, that massive amount of Oric data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Oric Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Oric Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Oric Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Oric Pharmaceuticals alpha.
Oric Pharmaceuticals Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Acquisition by Richard Heyman of 53700 shares of Oric Pharmaceuticals subject to Rule 16b-3 | 09/06/2024 |
2 | OpenBench and ORIC Pharmaceuticals Launch Success-Driven Discovery Collaboration | 09/17/2024 |
3 | Disposition of 2089 shares by Multani Pratik S of Oric Pharmaceuticals at 3.25 subject to Rule 16b-3 | 09/19/2024 |
4 | ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635 | 10/04/2024 |
5 | ORIC Pharmaceuticals Trading Up 4.5 percent Heres Why | 10/14/2024 |
6 | Candid Therapeutics Appoints Highly Accomplished Industry Leaders Angie You, Ph.D. and Dan Puckett to its Board of Directors | 10/16/2024 |
7 | Acquisition by Chacko Jacob of 510000 shares of Oric Pharmaceuticals at 9.14 subject to Rule 16b-3 | 11/01/2024 |
8 | ORIC - Oric Pharmaceuticals, Inc. Latest Stock News Market Updates - StockTitan | 11/06/2024 |
9 | ORIC Pharmaceuticals Outperform Rating Reaffirmed at Wedbush | 11/13/2024 |
10 | ORIC Pharmaceuticals to Participate in Upcoming Investor Confer | 11/25/2024 |
Complementary Tools for Oric Stock analysis
When running Oric Pharmaceuticals' price analysis, check to measure Oric Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oric Pharmaceuticals is operating at the current time. Most of Oric Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oric Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oric Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oric Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Transaction History View history of all your transactions and understand their impact on performance |